Vargas-HitosJASoriano-MaldonadoAMartínez-BordonadoJSánchez-BernáIFernández-BergésDSabioJM. Association of resting heart rate with arterial stiffness and low-grade inflammation in women with systemic lupus erythematosus. Angiology. 2018;69(8):672–6.
2.
LiuYKaplanMJ. Cardiovascular disease in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(5):441–8.
3.
IcliACureECureMC. Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus. Angiology. 2016;67(8):749–55.
4.
WheltonSPNarlaVBlahaMJ. Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2014;113(4):644–9.
5.
JensenMTSuadicaniPHeinHOGyntelbergF. Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the Copenhagen Male Study. Heart. 2013;99(12):882–7.
6.
YilmazSSenFAkbogaMK. The relationship between resting heart rate and syntax score in patients with stable coronary artery disease. Angiology. 2017;68(2):168–73.
7.
ZareifarSFarahmand FarMRGolfeshanFCohanN. Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP. J Clin Lab Anal. 2014;28(3):245–8.
8.
HanssonGK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95.
9.
DemirVYilmazSAkbogaMK. Association of lymphocyte-monocyte ratio and monocyte-to-high-density lipoprotein ratio with the presence and severity of rheumatic mitral valve stenosis [published ahead of print August 3, 2017]. Biomark Med. doi: 10.2217/bmm-2017-0036
10.
AkbogaMKCanpolatUSahinarslanA. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis. 2015;240(1):110–4.
